1. Home
  2. OCS vs BELFB Comparison

OCS vs BELFB Comparison

Compare OCS & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • BELFB
  • Stock Information
  • Founded
  • OCS 2003
  • BELFB 1949
  • Country
  • OCS Switzerland
  • BELFB United States
  • Employees
  • OCS N/A
  • BELFB N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • BELFB
  • Sector
  • OCS Health Care
  • BELFB
  • Exchange
  • OCS Nasdaq
  • BELFB Nasdaq
  • Market Cap
  • OCS 689.8M
  • BELFB 865.9M
  • IPO Year
  • OCS N/A
  • BELFB N/A
  • Fundamental
  • Price
  • OCS $18.76
  • BELFB $71.55
  • Analyst Decision
  • OCS Strong Buy
  • BELFB Strong Buy
  • Analyst Count
  • OCS 4
  • BELFB 3
  • Target Price
  • OCS $30.25
  • BELFB $98.33
  • AVG Volume (30 Days)
  • OCS 28.7K
  • BELFB 93.1K
  • Earning Date
  • OCS 05-20-2025
  • BELFB 04-24-2025
  • Dividend Yield
  • OCS N/A
  • BELFB 0.38%
  • EPS Growth
  • OCS N/A
  • BELFB N/A
  • EPS
  • OCS N/A
  • BELFB 3.42
  • Revenue
  • OCS $757,024.00
  • BELFB $558,940,000.00
  • Revenue This Year
  • OCS $49.27
  • BELFB $22.35
  • Revenue Next Year
  • OCS $1,920.31
  • BELFB $5.36
  • P/E Ratio
  • OCS N/A
  • BELFB $21.50
  • Revenue Growth
  • OCS N/A
  • BELFB N/A
  • 52 Week Low
  • OCS $10.79
  • BELFB $58.00
  • 52 Week High
  • OCS $23.08
  • BELFB $92.61
  • Technical
  • Relative Strength Index (RSI)
  • OCS 57.04
  • BELFB 57.60
  • Support Level
  • OCS $18.01
  • BELFB $67.50
  • Resistance Level
  • OCS $19.50
  • BELFB $74.29
  • Average True Range (ATR)
  • OCS 0.72
  • BELFB 3.12
  • MACD
  • OCS 0.18
  • BELFB 0.94
  • Stochastic Oscillator
  • OCS 76.19
  • BELFB 95.63

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

Share on Social Networks: